Characterisation of Mutations in Cytogenetically Normal Acute Myeloid Leukaemia Patients With Triple-Negative FLT3-ITD NPM1 CEBPA Subgroup Using Targeted Next-Generation Sequencing. Int. Med. Res. J. 2026, 11 (1). https://doi.org/10.63719/imrj.2025.11.01.003.